Epigallocatechin-3-Gallate Provides Protection Against Alzheimer’s Disease-Induced Learning and Memory Impairments in Rats

References

• DeTureMA, DicksonDW. The neuropathological diagnosis of Alzheimer’s disease. Mol Neurodegener. 2019;14(1):32. doi:10.1186/s13024-019-0333-531375134
   PubMed Web of Science ®Google Scholar
• JinY, XuK, ChenQ, et al. Simvastatin inhibits the development of radioresistant esophageal cancer cells by increasing the radiosensitivity and reversing EMT process via the PTEN-PI3K/AKT pathway. Exp Cell Res. 2018;362(2):362–369. doi:10.1016/j.yexcr.2017.11.03729208461
   PubMed Web of Science ®Google Scholar
• WongMW, BraidyN, PoljakA, SachdevPS. The application of lipidomics to biomarker research and pathomechanisms in Alzheimer’s disease. Curr Opin Psychiatry. 2017;30(2):136–144. doi:10.1097/YCO.000000000000030328002106
   PubMed Web of Science ®Google Scholar
• MoosaviF, HosseiniR, SasoL, FiruziO. Modulation of neurotrophic signaling pathways by polyphenols. Drug Des Devel Ther. 2016;10:(23–42. doi:10.2147/DDDT.S96936
   Web of Science ®Google Scholar
• ObrenovichM, TabrezS, SiddiquiB, McCloskeyB, PerryG. The microbiota-gut-brain axis-heart shunt Part II: prosaic foods and the brain-heart connection in Alzheimer disease. Microorganisms. 2020;8(4). doi:10.3390/microorganisms8040493
   Web of Science ®Google Scholar
• JabirNR, KhanFR, TabrezS. Cholinesterase targeting by polyphenols: a therapeutic approach for the treatment of Alzheimer’s disease. CNS Neurosci Ther. 2018;24(9):753–762. doi:10.1111/cns.1297129770579
   PubMed Web of Science ®Google Scholar
• IslamMT, TabrezS, JabirNR, et al. An Insight into the therapeutic potential of major coffee components. Curr Drug Metab. 2018;19(6):544–556. doi:10.2174/138920021966618030215455129512445
   PubMed Web of Science ®Google Scholar
• ZhangY, HeF, HuaT, SunQ. Green tea polyphenols ameliorate ethanol-induced spatial learning and memory impairments by enhancing hippocampus NMDAR1 expression and CREB activity in rats. Neuroreport. 2018;29(18):1564–1570. doi:10.1097/WNR.000000000000115230371539
   PubMed Web of Science ®Google Scholar
• LiH, WuX, WuQ, et al. Green tea polyphenols protect against okadaic acid-induced acute learning and memory impairments in rats. Nutrition. 2014;30(3):337–342. doi:10.1016/j.nut.2013.08.02124484683
   PubMed Web of Science ®Google Scholar
• XingL, ZhangH, QiR, TsaoR, MineY. Recent advances in the understanding of the health benefits and molecular mechanisms associated with green tea polyphenols. J Agric Food Chem. 2019;67(4):1029–1043. doi:10.1021/acs.jafc.8b0614630653316
   PubMed Web of Science ®Google Scholar
• ChesserAS, GaneshanV, YangJ, JohnsonGV. Epigallocatechin-3-gallate enhances clearance of phosphorylated tau in primary neurons. Nutr Neurosci. 2016;19(1):21–31. doi:10.1179/1476830515Y.000000003826207957
   PubMed Web of Science ®Google Scholar
• WinerJR, ManderBA, HelfrichRF, et al. Sleep as a potential biomarker of tau and beta-amyloid burden in the human brain. J Neurosci. 2019;39(32):6315–6324. doi:10.1523/JNEUROSCI.0503-19.201931209175
   PubMed Web of Science ®Google Scholar
• IslamBU, TabrezS. Management of Alzheimer’s disease-An insight of the enzymatic and other novel potential targets. Int J Biol Macromol. 2017;97:(700–709. doi:10.1016/j.ijbiomac.2017.01.076
   Web of Science ®Google Scholar
• TackenbergC, KulicL, NitschRM. Familial Alzheimer’s disease mutations at position 22 of the amyloid beta-peptide sequence differentially affect synaptic loss, tau phosphorylation and neuronal cell death in an ex vivo system. PLoS One. 2020;15(9):e0239584. doi:10.1371/journal.pone.023958432966331
   PubMed Web of Science ®Google Scholar
• Rezai-ZadehK, ArendashGW, HouH, et al. Green tea epigallocatechin-3-gallate (EGCG) reduces beta-amyloid mediated cognitive impairment and modulates tau pathology in Alzheimer transgenic mice. Brain Res. 2008;1214:(177–187. doi:10.1016/j.brainres.2008.02.107
   Web of Science ®Google Scholar
• LeeJW, LeeYK, BanJO, et al. Green tea (-)-epigallocatechin-3-gallate inhibits beta-amyloid-induced cognitive dysfunction through modification of secretase activity via inhibition of ERK and NF-kappaB pathways in mice. J Nutr. 2009;139(10):1987–1993. doi:10.3945/jn.109.10978519656855
   PubMed Web of Science ®Google Scholar
• LaneCA, HardyJ, SchottJM. Alzheimer’s disease. Eur J Neurol. 2018;25(1):59–70. doi:10.1111/ene.1343928872215
   PubMed Web of Science ®Google Scholar
• CheignonC, TomasM, Bonnefont-RousselotD, FallerP, HureauC, CollinF. Oxidative stress and the amyloid beta peptide in Alzheimer’s disease. Redox Biol. 2018;14:(450–464. doi:10.1016/j.redox.2017.10.014
   Web of Science ®Google Scholar
• ZameerS, KaundalM, VohoraD, AliJ, Kalam NajmiA, AkhtarM. Ameliorative effect of alendronate against intracerebroventricular streptozotocin induced alteration in neurobehavioral, neuroinflammation and biochemical parameters with emphasis on Abeta and BACE-1. Neurotoxicology. 2019;70:(122–134. doi:10.1016/j.neuro.2018.11.012
   Web of Science ®Google Scholar
• JulienC, TomberlinC, RobertsCM, et al. In vivo induction of membrane damage by beta-amyloid peptide oligomers. Acta Neuropathol Commun. 2018;6(1):131. doi:10.1186/s40478-018-0634-x30497524
   PubMed Web of Science ®Google Scholar
• Cortes-GomezMA, Llorens-AlvarezE, AlomJ, et al. Tau phosphorylation by glycogen synthase kinase 3beta modulates enzyme acetylcholinesterase expression. J Neurochem. 2020. doi:10.1111/jnc.15189
   Web of Science ®Google Scholar
• JabirNR, ShakilS, TabrezS, KhanMS, RehmanMT, AhmedBA. In silico screening of glycogen synthase kinase-3beta targeted ligands against acetylcholinesterase and its probable relevance to Alzheimer’s disease. J Biomol Struct Dyn. 2020;1–10. doi:10.1080/07391102.2020.1784796
   Web of Science ®Google Scholar
• TabrezS, DamanhouriGA. Computational and kinetic studies of acetylcholine esterase inhibition by phenserine. Curr Pharm Des. 2019;25(18):2108–2112. doi:10.2174/138161282566619061814101531258059
   PubMed Web of Science ®Google Scholar
• LiX, WangSW, LiXL, YuFY, CongHM. Knockdown of long non-coding RNA TUG1 depresses apoptosis of hippocampal neurons in Alzheimer’s disease by elevating microRNA-15a and repressing ROCK1 expression. Inflamm Res. 2020;69(9):897–910. doi:10.1007/s00011-020-01364-832577774
   PubMed Web of Science ®Google Scholar
• Morishima-KawashimaM, HasegawaM, TakioK, et al. Hyperphosphorylation of tau in PHF. Neurobiol Aging. 1995;16(3):365–380. doi:10.1016/0197-4580(95)00027-c7566346
   PubMed Web of Science ®Google Scholar
• ChoiYT, JungCH, LeeSR, et al. The green tea polyphenol (-)-epigallocatechin gallate attenuates beta-amyloid-induced neurotoxicity in cultured hippocampal neurons. Life Sci. 2001;70(5):603–614. doi:10.1016/s0024-3205(01)01438-211811904
   PubMed Web of Science ®Google Scholar
• OnoK, YoshiikeY, TakashimaA, HasegawaK, NaikiH, YamadaM. Potent anti-amyloidogenic and fibril-destabilizing effects of polyphenols in vitro: implications for the prevention and therapeutics of Alzheimer’s disease. J Neurochem. 2003;87(1):172–181. doi:10.1046/j.1471-4159.2003.01976.x12969264
   PubMed Web of Science ®Google Scholar
• ZhangH, LaiQ, LiY, LiuY, YangM. Learning and memory improvement and neuroprotection of Gardenia jasminoides (Fructus gardenia) extract on ischemic brain injury rats. J Ethnopharmacol. 2017;196:(225–235. doi:10.1016/j.jep.2016.11.042
   Web of Science ®Google Scholar
• BaoJ, LiuW, ZhouHY, et al. Epigallocatechin-3-gallate alleviates cognitive deficits in APP/PS1 mice. Curr Med Sci. 2020;40(1):18–27. doi:10.1007/s11596-020-2142-z32166661
   PubMed Web of Science ®Google Scholar
• RasoolijaziH, JoghataieMT, RoghaniM, NobakhtM. The beneficial effect of (-)-epigallocatechin-3-gallate in an experimental model of Alzheimer’s disease in rat: a behavioral analysis. Iran Biomed J. 2007;11(4):237–243.18392085
   PubMedGoogle Scholar
• Ul islamB, KhanMS, JabirNR, KamalMA, TabrezS. Elucidating Treatment of Alzheimer’s disease via different receptors. Curr Top Med Chem. 2017;17(12):1400–1407. doi:10.2174/156802661766617010316371528049400
   PubMed Web of Science ®Google Scholar
• PervinM, UnnoK, TakagakiA, IsemuraM, NakamuraY. Function of green tea catechins in the brain: epigallocatechin gallate and its metabolites. Int J Mol Sci. 2019;20(15):3630. doi:10.3390/ijms20153630
   Web of Science ®Google Scholar
• CanoA, EttchetoM, ChangJH, et al. Dual-drug loaded nanoparticles of Epigallocatechin-3-gallate (EGCG)/ascorbic acid enhance therapeutic efficacy of EGCG in a APPswe/PS1dE9 Alzheimer’s disease mice model. J Control Release. 2019;301:(62–75. doi:10.1016/j.jconrel.2019.03.010
   Web of Science ®Google Scholar
• EttchetoM, CanoA, ManzinePR, et al. Epigallocatechin-3-Gallate (EGCG) improves cognitive deficits aggravated by an obesogenic diet through modulation of unfolded protein response in APPswe/PS1dE9 Mice. Mol Neurobiol. 2020;57(4):1814–1827. doi:10.1007/s12035-019-01849-631838720
   PubMed Web of Science ®Google Scholar
• XuY, ZhangJJ, XiongL, ZhangL, SunD, LiuH. Green tea polyphenols inhibit cognitive impairment induced by chronic cerebral hypoperfusion via modulating oxidative stress. J Nutr Biochem. 2010;21(8):741–748. doi:10.1016/j.jnutbio.2009.05.00219615878
   PubMed Web of Science ®Google Scholar
• HaqueAM, HashimotoM, KatakuraM, HaraY, ShidoO. Green tea catechins prevent cognitive deficits caused by Abeta1-40 in rats. J Nutr Biochem. 2008;19(9):619–626. doi:10.1016/j.jnutbio.2007.08.00818280729
   PubMed Web of Science ®Google Scholar
• ZhengQ, KebedeMT, KemehMM, et al. Inhibition of the self-assembly of abeta and of tau by polyphenols: mechanistic studies. Molecules. 2019;24(12):2316. doi:10.3390/molecules24122316
   Web of Science ®Google Scholar
• GuerouxM, FleauC, SlozeckM, LaguerreM, PianetI. Epigallocatechin 3-Gallate as an inhibitor of tau phosphorylation and aggregation: a molecular and structural insight. J Prev Alzheimers Dis. 2017;4(4):218–225. doi:10.14283/jpad.2017.3529181486
   PubMed Web of Science ®Google Scholar
• LiJ, ChenW, YiY, TongQ. miR-219-5p inhibits tau phosphorylation by targeting TTBK1 and GSK-3beta in Alzheimer’s disease. J Cell Biochem. 2019;120(6):9936–9946. doi:10.1002/jcb.2827630556160
   PubMed Web of Science ®Google Scholar
• WuH, WeiS, HuangY, et al. Abeta monomer induces phosphorylation of Tau at Ser-214 through beta2AR-PKA-JNK signaling pathway. FASEB J. 2020;34(4):5092–5105. doi:10.1096/fj.201902230RR32067279
   PubMed Web of Science ®Google Scholar
• GremerL, ScholzelD, SchenkC, et al. Fibril structure of amyloid-beta (1-42) by cryo-electron microscopy. Science. 2017;358(6359):116–119. doi:10.1126/science.aao282528882996
   PubMed Web of Science ®Google Scholar
• BlennowK, MattssonN, SchollM, HanssonO, ZetterbergH. Amyloid biomarkers in Alzheimer’s disease. Trends Pharmacol Sci. 2015;36(5):297–309. doi:10.1016/j.tips.2015.03.00225840462
   PubMed Web of Science ®Google Scholar
• PrasanthMI, SivamaruthiBS, ChaiyasutC, TencomnaoTA. Review of the role of green tea (Camellia sinensis) in antiphotoaging, stress resistance, neuroprotection, and autophagy. Nutrients. 2019;11(2):474. doi:10.3390/nu11020474
   PubMed Web of Science ®Google Scholar
• JiangY, GaoH, TurduG. Traditional Chinese medicinal herbs as potential AChE inhibitors for anti-Alzheimer’s disease: a review. Bioorg Chem. 2017;75:(50–61. doi:10.1016/j.bioorg.2017.09.004
   Web of Science ®Google Scholar
• AliB, JamalQM, ShamsS, et al. In silico analysis of green tea polyphenols as inhibitors of AChE and BChE enzymes in Alzheimer’s disease treatment. CNS Neurol Disord Drug Targets. 2016;15(5):624–628. doi:10.2174/187152731566616032111060726996169
   PubMed Web of Science ®Google Scholar